WallStSmart

Keurig Dr Pepper Inc (KDP)vsArcadia Biosciences Inc (RKDA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Keurig Dr Pepper Inc generates 356016% more annual revenue ($16.94B vs $4.76M). KDP leads profitability with a 10.8% profit margin vs -195.9%. KDP earns a higher WallStSmart Score of 59/100 (C).

KDP

Buy

59

out of 100

Grade: C

Growth: 4.7Profit: 6.0Value: 7.3Quality: 5.5
Piotroski: 5/9Altman Z: 1.09

RKDA

Hold

38

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 6.7Quality: 5.3
Piotroski: 3/9Altman Z: -62.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KDPUndervalued (+57.1%)

Margin of Safety

+57.1%

Fair Value

$69.64

Current Price

$30.53

$39.11 discount

UndervaluedFair: $69.64Overvalued
RKDAUndervalued (+37.9%)

Margin of Safety

+37.9%

Fair Value

$2.80

Current Price

$1.03

$1.77 discount

UndervaluedFair: $2.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KDP1 strengths · Avg: 8.0/10
Price/BookValuation
1.6x8/10

Reasonable price relative to book value

RKDA2 strengths · Avg: 9.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

EPS GrowthGrowth
28.5%8/10

Earnings expanding 28.5% YoY

Areas to Watch

KDP4 concerns · Avg: 2.5/10
Return on EquityProfitability
7.3%3/10

ROE of 7.3% — below average capital efficiency

Debt/EquityHealth
1.023/10

Elevated debt levels

EPS GrowthGrowth
-47.7%2/10

Earnings declined 47.7%

Altman Z-ScoreHealth
1.092/10

Distress zone — elevated risk

RKDA4 concerns · Avg: 2.5/10
Market CapQuality
$1.94M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-323.1%2/10

ROE of -323.1% — below average capital efficiency

Revenue GrowthGrowth
-8.3%2/10

Revenue declined 8.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : KDP

The strongest argument for KDP centers on Price/Book. PEG of 1.06 suggests the stock is reasonably priced for its growth.

Bull Case : RKDA

The strongest argument for RKDA centers on Price/Book, EPS Growth.

Bear Case : KDP

The primary concerns for KDP are Return on Equity, Debt/Equity, EPS Growth.

Bear Case : RKDA

The primary concerns for RKDA are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

KDP profiles as a value stock while RKDA is a turnaround play — different risk/reward profiles.

RKDA carries more volatility with a beta of 0.50 — expect wider price swings.

KDP is growing revenue faster at 9.4% — sustainability is the question.

KDP generates stronger free cash flow (165M), providing more financial flexibility.

Bottom Line

KDP scores higher overall (59/100 vs 38/100). RKDA offers better value entry with a 37.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Keurig Dr Pepper Inc

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Keurig Dr Pepper Inc. is a beverage company in the United States and internationally. The company is headquartered in Burlington, Massachusetts.

Arcadia Biosciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Arcadia Biosciences, Inc. is dedicated to developing various crop productivity traits primarily in hemp, wheat, and soybeans. The company is headquartered in Davis, California.

Visit Website →

Want to dig deeper into these stocks?